George Roeth
Analyst · Chris Carey with Bank of America Merrill Lynch. Please proceed with your question
Thank you, Steve. Our first quarter is the typically our smallest quarter of the year, last year representing to 10% of non GAAP earnings with the challenging one from a year-over-year perspective. But having said that, aside from some unanticipated key customer shipment timing issues, the quarter playing out mostly as we expected, I’m pleased to say that we remain on track with our strategy and deliver our fiscal 19 EPS commitment of a $1.80 per share or higher. As we said last quarter, we expected our first quarter comparison versus last year to be the most challenging for the year with higher cost largely absent any corresponding price increase and so our second quarter and higher interest expense to be issued unique to the quarter. We also noted that our recent acquisitions would have a significant negative impact in both the first and second quarter and that our higher effective tax rate and additional shares outstanding would be drag on our earnings for the entire year. That is all playing up to be true. IN Q1, we grew overall sales 5% driven by our fiscal 2018 acquisitions. On an organic basis, sales declined 2%; however, excluding a timing shift in large Garden customers orders as compared to last year, organic sales from the Company would have increased. It's important to note that our January sales increases over the prior year consistent with this shift, reassuringly our Garden consumptions while offseason was never the less up substantially plus 9% that are largest customers in the first quarter. Organic sales for the first quarter were also negatively impacted by the challenges in our Pet animal health business, where sales declined as a new competition from a former supplier and behavior modification market, continue to impact the results during the time of some product performance challenges. We’re launching products improvement mid-to-late second quarter and we expect to be investing behind this business throughout the remainder of fiscal year. Having said all this, I’m pleased to tell you that total company sales for the fiscal year to-date period through January are right where we expected them to be. Operating income, EBITDA and EPS declined in the first quarter; do not only for the factors I just mentioned, but also due to the inclusion of our recent acquisitions Bell Nursery and General Pet. These acquisitions have aided sales but negatively impacted margins and profitability in the quarter. Bell losses are substantial in the first quarter consistent with the extreme seasonal nature of the business and historical norms, and we’re not in last year's first quarter earnings for our company. That made for a difficult year-over-year comparison. And General Pet being a distribution business earned relatively low margins. A third factor impacting operating margin and EBITDA were higher freight, labor and raw material costs. However, our range of freight increases were implemented in January which will help mitigate the cost inflation pressures. With this and our cost savings initiatives, we continue to project margins to grow in the back half of the year. As a whole, we continue to expect results for the second half of the year to be more favorable, driven by the lapping of the Bell and General Pet acquisitions at the end of the second quarter. The array of price increase affective in January in conjunction with less challenging cost increases versus last year, and importantly sales growth through innovation and distribution gain to key customers. In addition, we expect several other factors will also a year-over-year comparisons for the back half of the year. These are more normalized weather passage, unfavorable weather significantly impacted last year's second half Garden results and certain of our Animal Health businesses. Our more favorable projected mix of sales after a negative mix impact over the last several quarters due in part to unfavorable weather, the ramp up of our lower margin pet distribution Kroger business and the aforementioned challenges in our behavior modification business. And lastly, the positive impact we continue cross savings 1% to 2% annually. Please keep in mind that we do expect also be spending more on demand activities this year than we did last year, as we go back spending a year ago to offset weakness and results due to the unfavorable weather. Nonetheless, we still estimate operating margins to improve in the second half of the year. I do want to point out that while our second quarter will benefit somewhat from the timing shift and impact January and the recent price increases. it still faces a difficult comparison with the second quarter of last year. Due to the dilutive nature of the recent acquisitions, difficult year-over-year cost comparisons and comping of 6% organic sales gain in a period year ago. So, we currently expect organic operating income in the second quarter to be flat to modestly up this year ago. Total operating income will very likely be down, negatively impacted by the Bell acquisitions. Second quarter EPS much like the rest of the year will also be burned by higher tax rate and greater number of shares outstanding. However, we do remain optimistic about the full year and are reaffirming our previous guidance. Now, I want to give you some detail on the new products we’re launching this year. We expect that new products will be to dealing to Central continue to build on its share gain of the last few years. In the Garden segment, we’re introducing PENNINGTON Lawn Booster, a new combination of grass seed, fertilizer and soil enhancement that we believe is a technological advancement in the category. We have also developed a new technology we are utilizing in our PENNINGTON Smart Blend and grass seed products which will be launched this month. In addition, we will continue the roll out of the new active ingredient for our seven products, which is effective against the greater number of tests and last longer than both our old formulation and our competitor's product. We introduced the veterinary formulation last year and we've expanded distribution in 2019 while displaced in competition at major retailers. Finally, we’re deploying new technology in some of our private label fertilizing control products as we continue to improve product efficacy in our value proposition. We’re excited about the potential of these new Garden products and the value and benefits they agree to consumers. We believe, the advance technology we bring to the marketplace is a clear differentiator for Central and enable us outperform in a competitive marketplace. Our Pet segment also has a number of new products rolling out this year. One is a new brand of minimally processed dog treats and chews called Farm to Paws. This collection of single and limited ingredient products was developed for the pet independent and big box specialty channels. In our Animal Health area, we’re launching new fly and flea and tick shampoo innovation that is rapidly gaining distribution at major retailers. In the Aquatics area, we are leveraging our unique strengths strength to help our retail partners solve complex categories using growth sales. For example, we’re introducing nano shrimp in the United States while popular in Europe and Asia nano shrimp is untapped market in the U.S. because nano shrimp thrives in soft water, which is not prevalent here in the U.S. Secret breeding capabilities enabled us to develop the nano shrimp that thrives in hard water environment. And with our Aqueon brand complimenting innovation on tanks and filters, we have developed a comprehensive solution for our customers. We already tested initiatives with one major retailer and have an agreement to expand our platform more broadly with them. On a negative note, we have learned in a last few weeks for the major retailer is existing, the live fish category, where there will be an impact with Central, we expect it to be manageable and as incorporated in our go forward estimates. Importantly, we will be looking to recapture demand that will go elsewhere. The products opportunity is still rather large in fact we have already partnered successfully with the largest pet specially chain that didn't carry live fish -- supply live fish equipment and consumer supply. With started to tap in a couple of stores is now expected to be expanded over the next two years. Finally, on the M&A front, we just close on a deal to buy the remaining 55% stake in our joint venture with Arden Companies. Arden is the leading manufacturer of outdoor cushion and pillows. We took a 45% position in Arden back in March 2017 with an option to purchase the rest in the future. Over the past year and half, we have had the opportunities to assess the business more thoroughly and decided to acquire the rest of the Company. We close on this transaction on February 2nd. While the relatively modest transaction, Arden is in a wide space to make sense for us. We acquired at a price that was at the bottom end of our historical multiple range. We already did business with the same customer that is Arden, and the mechanics of the business are not similar to the dog vetting business we have acquired over the last few years. We believe there are significant synergies between these businesses that we can take advantage of. We will be reporting this acquisition as part of our Garden segment and I will leave it to Niko to go over the financial implications of the transaction. On the broader M&A front, we continue to have an active pipeline and evaluating deal of various sizes. Unfortunately, we can’t guarantee when and if deals will close. It's just the nature of beast. Rest assured, we remain active disciplined, motivated, seekers of value creating deals and remain bullish. I would now like to turn it over to Niko, who will give some additional details around the results.